The liver can be considered an ideal target to design gene therapy strategi
es because of the unique properties of hepatic cells. The great amount of w
ork carried out in this field clearly delineates the quality of the new app
roaches that have been developed in the last few years and demonstrates the
feasibility of this strategy in a wide range of multi-factorial and inheri
ted disorders. However, improvement of current vectors to specifically and
efficiently deliver the therapeutic gene into the target cell remains a dau
nting problem. In this review, we will summarize the most important approac
hes that are currently under investigation, the pathological conditions tha
t can be treated by this strategy and the most important drawbacks that rem
ain to be overcome in order to achieve long-term and high-level gene expres
sion, fur J Gastroenterol Hepatol 11:421-429 (C) 1999 Lippincott Williams &
Wilkins.